A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma: The Tier Trial

Christopher P. Fox; Ayesha S. Ali; Dorothee Auer; Steffi Thust; Aimee E. Jackson; Louise Hopkins; Catherine Thomas; Nicolas Martinez-Calle; Graham P. Collins; Shireen Kassam; Josh Wright; David Lewis; Andres J. M. Ferreri; Sridhar Chaganti; Jeffery Smith; Kim Linton; Ian Chau; Dominic J. Culligan; Andrew Davies; Roderick Johnson; Kate Cwynarski

doi:10.1182/blood-2019-122830

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma: The Tier Trial

Christopher P. Fox, Ayesha S. Ali, Dorothee Auer, Steffi Thust, Aimee E. Jackson, Louise Hopkins, Catherine Thomas, Nicolas Martinez-Calle, Graham P. Collins, Shireen Kassam, Josh Wright, David Lewis, Andres J. M. Ferreri, Sridhar Chaganti, Jeffery Smith, Kim Linton, Ian Chau, Dominic J. Culligan, Andrew Davies, Roderick JohnsonKate Cwynarski

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/blood-2019-122830
Publication status	Published - 13 Nov 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2019-122830

Cite this

Fox, C. P., Ali, A. S., Auer, D., Thust, S., Jackson, A. E., Hopkins, L., Thomas, C., Martinez-Calle, N., Collins, G. P., Kassam, S., Wright, J., Lewis, D., Ferreri, A. J. M., Chaganti, S., Smith, J., Linton, K., Chau, I., Culligan, D. J., Davies, A., ... Cwynarski, K. (2019). A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma: The Tier Trial. Blood, 134. https://doi.org/10.1182/blood-2019-122830

@article{5267ba599e834611b78b9dbc084886c5,

title = "A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma: The Tier Trial",

author = "Fox, {Christopher P.} and Ali, {Ayesha S.} and Dorothee Auer and Steffi Thust and Jackson, {Aimee E.} and Louise Hopkins and Catherine Thomas and Nicolas Martinez-Calle and Collins, {Graham P.} and Shireen Kassam and Josh Wright and David Lewis and Ferreri, {Andres J. M.} and Sridhar Chaganti and Jeffery Smith and Kim Linton and Ian Chau and Culligan, {Dominic J.} and Andrew Davies and Roderick Johnson and Kate Cwynarski",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/blood-2019-122830",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

}

Fox, CP, Ali, AS, Auer, D, Thust, S, Jackson, AE, Hopkins, L, Thomas, C, Martinez-Calle, N, Collins, GP, Kassam, S, Wright, J, Lewis, D, Ferreri, AJM, Chaganti, S, Smith, J, Linton, K, Chau, I, Culligan, DJ, Davies, A, Johnson, R & Cwynarski, K 2019, 'A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma: The Tier Trial', Blood, vol. 134. https://doi.org/10.1182/blood-2019-122830

TY - JOUR

T1 - A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma

T2 - The Tier Trial

AU - Fox, Christopher P.

AU - Ali, Ayesha S.

AU - Auer, Dorothee

AU - Thust, Steffi

AU - Jackson, Aimee E.

AU - Hopkins, Louise

AU - Thomas, Catherine

AU - Martinez-Calle, Nicolas

AU - Collins, Graham P.

AU - Kassam, Shireen

AU - Wright, Josh

AU - Lewis, David

AU - Ferreri, Andres J. M.

AU - Chaganti, Sridhar

AU - Smith, Jeffery

AU - Linton, Kim

AU - Chau, Ian

AU - Culligan, Dominic J.

AU - Davies, Andrew

AU - Johnson, Roderick

AU - Cwynarski, Kate

PY - 2019/11/13

Y1 - 2019/11/13

U2 - 10.1182/blood-2019-122830

DO - 10.1182/blood-2019-122830

M3 - Meeting Abstract

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

ER -